Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Management of Patients With Non Small Cell Lung Cancer (NSCLC) Adenocarcinoma Tested for the Activating Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK)

NCT01167972 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01167972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01167972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Management of Patients With Non Small Cell Lung Cancer (NSCLC) Adenocarcinoma Tested for the Activating Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
September 30, 2012
Enrollment
2,000 (actual)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer